BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 1505125)

  • 21. The ras oncogene and tumour metastasis: observations on murine cells transfected with activated human c-Ha-ras.
    Wallace JS; Hayle AJ; Syms AJ; Cairney M; Tutty B; Gazzard A; Evans MF; Fleming KA; Tarin D
    Differentiation; 1989 Sep; 41(3):208-15. PubMed ID: 2693169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recessive (mediator-) revertants from c-H-ras oncogene-transformed NIH 3T3 cells: tumorigenicity in nude mice and transient anchorage and serum independence of the recovered tumor cells in culture.
    Omata-Yamada T; Yamada H; Lengyel P
    J Cell Physiol; 1991 Nov; 149(2):214-21. PubMed ID: 1748716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A BALB/c 3T3-transformed cell line suitable for transfection assay of metastasis-inducing genes.
    Tatsuka M; Ota T; Maeda M; Wada M; Yamagishi N; Taniguchi S; Seiki M; Odashima S
    Int J Cancer; 1997 Mar; 71(1):88-93. PubMed ID: 9096670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal diversity of the Kirsten-ras oncogene during tumor progression in athymic nude mice: mechanisms of amplification and rearrangement.
    Radinsky R; Kraemer PM; Proffitt MR; Culp LA
    Cancer Res; 1988 Sep; 48(17):4941-53. PubMed ID: 3409227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient alterations in the expression of protease and extracellular matrix genes during metastatic lung colonization by H-ras-transformed 10T1/2 fibroblasts.
    Gingras MC; Jarolim L; Finch J; Bowden GT; Wright JA; Greenberg AH
    Cancer Res; 1990 Jul; 50(13):4061-6. PubMed ID: 2191771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice.
    Liu M; Bryant MS; Chen J; Lee S; Yaremko B; Li Z; Dell J; Lipari P; Malkowski M; Prioli N; Rossman RR; Korfmacher WA; Nomeir AA; Lin CC; Mallams AK; Doll RJ; Catino JJ; Girijavallabhan VM; Kirschmeier P; Bishop WR
    Cancer Chemother Pharmacol; 1999; 43(1):50-8. PubMed ID: 9923541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of the metastatic phenotype of a mouse skin carcinoma cell line independent of E-cadherin expression and correlated with reduced Ha-ras oncogene products.
    Caulín C; López-Barcons L; Gonzáles-Garrigues M; Navarro P; Lozano E; Rodrigo I; Gamallo C; Cano A; Fabra A; Quintanilla M
    Mol Carcinog; 1996 Feb; 15(2):104-14. PubMed ID: 8599577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel activating mutation of the K-ras gene in human primary colon adenocarcinoma.
    Tsukuda K; Tanino M; Soga H; Shimizu N; Shimizu K
    Biochem Biophys Res Commun; 2000 Nov; 278(3):653-8. PubMed ID: 11095964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells.
    Nam SW; Clair T; Campo CK; Lee HY; Liotta LA; Stracke ML
    Oncogene; 2000 Jan; 19(2):241-7. PubMed ID: 10645002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transformation and amplification of the K-fgf proto-oncogene in NIH-3T3 cells, and induction of metastatic potential.
    Damen JE; Greenberg AH; Wright JA
    Biochim Biophys Acta; 1991 Sep; 1097(2):103-10. PubMed ID: 1911883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amplification and rearrangement of the Kirsten ras oncogene in virus-transformed BALB/c 3T3 cells during malignant tumor progression.
    Radinsky R; Kraemer PM; Raines MA; Kung HJ; Culp LA
    Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5143-7. PubMed ID: 3474646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct tumorigenic conversion of human gallbladder carcinoma cells by v-src but not by activated c-H-ras oncogene.
    Tatsumoto T; Nakano S; Shimizu K; Ono M; Esaki T; Ohshima K; Niho Y
    Int J Cancer; 1995 Apr; 61(2):206-13. PubMed ID: 7705949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between metastatic ability and H-ras oncogene expression in rat mammary cancer cells transfected with the v-H-ras oncogene.
    Kyprianou N; Isaacs JT
    Cancer Res; 1990 Mar; 50(5):1449-54. PubMed ID: 2105838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of the presence of adenovirus 5 E1a and E1b sequences on the pathology of rat embryonic fibroblasts transfected with activated c-Ha-ras and v-ras.
    Boghaert ER; Austin V; Zimmer SG
    Clin Exp Metastasis; 1991; 9(3):231-43. PubMed ID: 2060183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells.
    Hofmann M; Rudy W; Günthert U; Zimmer SG; Zawadzki V; Zöller M; Lichtner RB; Herrlich P; Ponta H
    Cancer Res; 1993 Apr; 53(7):1516-21. PubMed ID: 8453616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistence of Ha-ras-induced metastatic potential of SP1 mouse mammary tumors despite loss of the Ha-ras shuttle vector.
    Schlatter B; Waghorne CG
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):9986-90. PubMed ID: 1438249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic factors and suppression of metastatic ability of v-Ha-ras-transfected rat mammary cancer cells.
    Ichikawa T; Ichikawa Y; Isaacs JT
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1607-10. PubMed ID: 1542651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
    Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
    Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumorigenicity, metastasis and suppression of MHC class-I expression in murine fibroblasts transformed by mutant v-ras deficient in GTP binding.
    Lu YY; Blair DG; Segal S; Shih TY; Clanton DJ
    Int J Cancer Suppl; 1991; 6():45-53. PubMed ID: 2066184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EJ/ras neoplastic transformation of simian virus 40-immortalized human uroepithelial cells: a rare event.
    Christian BJ; Kao CH; Wu SQ; Meisner LF; Reznikoff CA
    Cancer Res; 1990 Aug; 50(15):4779-86. PubMed ID: 2164447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.